Searchable abstracts of presentations at key conferences in obesity
Previous issue | Volume 3 | OU2021 | Next issue

Obesity Update 2021

Online, United Kingdom
30 Jun 2021 - 01 Jul 2021

Card image cap
Registration for Obesity Update 2021 is now open! Join us virtually over two half days on Wednesday 30 June and Thursday 1 July 2021, to gain new insights and learn techniques from UK experts in obesity. By doing so you'll gain the skills needed to improve your clinical outcomes.

ob0003p1 | All items | OU2021

Development of severe gastroparesis and gastric food bezoar following administration of glucagon-like peptide 1-receptor agonist (GLP1-RA) therapy

Preda Veronica , Khoo Su Yee , Lord Reginald

With the global increase in obesity and diabetes, the use of weight negative therapy, such as the glucagon-like peptide -1 receptor agonists (GLP-1 RA) are increasing. The most common side effects with the GLP-1RA are gastrointestinal symptoms, mainly nausea. Other common adverse effects include headache, injection site reactions, and are usually minor and do not result in cessation of therapy. GLP-1RA are also associated with slowed gastric emptying, by virtue of their mode o...

ob0003p2 | All items | OU2021

Resistant Hypocalcemia in a patient after Roux-en-Y gastric bypass

Boharoon Hessa , Miras Alexander

Introduction: It is known that bariatric operations cause nutritional deficiencies especially calcium and vitamin D. Reported hypocalcemia after bariatric surgery ranges from 1% after Roux-en-Y gastric bypass (RYGB) to 25% after bilio-pancreatic diversion-duodenal switch. This is mainly the result of bypassing the preferential sites for calcium and vitamin D absorption. Apart from the bariatric operations, hypocalcemia commonly...

ob0003p3 | All items | OU2021

Gender differences in cardiometabolic abnormalities across different BMI categories

Agius Rachel , Pace Nikolai , Fava Stephen

Background: Not all obese individuals exhibit abnormal cardiometabolic parameters. These are termed as being metabolically healthy obese (MHO). Conversely some normal weight individuals exhibit adverse cardiometabolic parameters and are described as being metabolically unhealthy normal weight (MUHNW). Visceral adiposity is known to be strongly associated with cardiometabolic risk than subcutaneous adiposity. Furthermore, there are gender differences in distribution of fat and ...

ob0003p4 | All items | OU2021

Vitamin D Receptor (VDR) polymorphisms & metabolic health status in a maltese cohort

Micallef Kay Lee , Agius Rachel , Fava Stephen , Paul Pace Nikolai

Background: Several studies have investigated the association between vitamin D receptor (VDR) variants and the risk of cardiometabolic complications. The pleiotropic action of VDR in extra-skeletal tissues gives physiologic plausibility to the associations between VDR variants and metabolic health, particularly in obese individuals. Whilst multiple conflicting findings have been reported, clinical data has shown that despite an increase in physical activity and nurturing heal...

ob0003p5 | All items | OU2021

Energy expenditure trends in patients following roux-en-y gastric bypass surgery

Tabbakh Yasmin , Alexiadou Kleopatra , Malallah Khalefah , Tsironis Christos , Hakky Sherif , Purkayastha Sanjay , Tan Tricia , Ahmed Ahmed

Background: Resting energy expenditure (REE) and diet induced thermogenesis (DIT) are known to influence long term maintenance of weight loss following bariatric surgery. Although it is known that fat free mass (FFM) contributes to REE to a greater extent than fat mass (FM), there has been relatively little work looking at the REE:FFM ratio and its overall effect on and relationship to weight loss.Aim: To assess weight loss, REE and REE:MMT ratio in pati...